Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve
Sven Knecht1,2, Beat Schaer1,2, Tobias Reichlin1,2,3
1Cardiology/Electrophysiology University Hospital Basel University Basel Basel Switzerland.
Insights
Left bundle branch block (LBBB) after TAVI is common. An electrophysiology study using the HV-interval effectively identifies patients at risk for high-grade atrioventricular block (HAVB), enabling tailored management.
Area of Science:
- Cardiology
- Electrophysiology
- Interventional Cardiology
Background:
- Left bundle branch block (LBBB) frequently occurs post-transcatheter aortic valve implantation (TAVI).
- LBBB is a known predictor of subsequent high-grade atrioventricular block (HAVB).
- A standardized method to identify LBBB patients at risk for HAVB after TAVI is lacking.
Purpose of the Study:
- To assess the safety and efficacy of an electrophysiology study-guided strategy for managing LBBB patients post-TAVI.
- To stratify patients based on HV-interval measurements to predict HAVB development.
Main Methods:
- Prospective analysis of 56 patients with LBBB post-TAVI.
- Electrophysiology study to measure the HV-interval the day after TAVI.
- Patients with HV-interval ≤55 ms received a loop recorder; those with HV-interval >55 ms received a pacemaker.
Main Results:
- High-grade atrioventricular block (HAVB) occurred in 10% of patients with normal HV-intervals versus 53% with prolonged HV-intervals (P<0.001).
- The HV-interval >55 ms was the sole predictor for HAVB.
- The negative predictive value of HV ≤55 ms for detecting HAVB was 90% over 12 months.
Conclusions:
- An electrophysiology study-tailored strategy using an HV-interval cutoff of >55 ms is feasible and safe for stratifying LBBB patients post-TAVI.
- This approach effectively predicts HAVB development over a 12-month follow-up period.
- The strategy aids in personalized risk assessment and management of post-TAVI LBBB.
Abstract:
Background Left bundle branch block (LBBB) is common after transcatheter aortic valve implantation (TAVI) and is an indicator of subsequent high-grade atrioventricular block (HAVB). No standardized protocol is available to identify LBBB patients at risk for HAVB. The aim of the current study was to evaluate the safety and efficacy of an electrophysiology study tailored strategy in patients with LBBB after TAVI. Methods and Results We prospectively analyzed consecutive patients with LBBB after TAVI. An electrophysiology study was performed to measure the HV-interval the day following TAVI. In patients with normal His-ventricular (HV)-interval ≤55 ms, a loop recorder was implanted (ILR-group), whereas pacemaker implantation was performed in patients with prolonged HV-interval >55 ms (PM-group). The primary end point was occurrence of HAVB during a follow-up of 12 months. Secondary end points were symptoms, hospitalizations, adverse events because of device implantation or electrophysiology study, and death. Of 373 patients screened after TAVI, 56 patients (82±6 years, 41% male) with LBBB were included. HAVB occurred in 4 of 41 patients (10%) in the ILR-group and in 8 of 15 patients (53%) in the PM-group (P<0.001). We did not identify other predictors for HAVB than the HV interval. The negative predictive value for the cut-off of HV 55 ms to detect HAVB was 90%. No HAVB-related syncope occurred in the 2 groups. Conclusions An electrophysiology study tailored strategy to LBBB after TAVI with a cut-off of HV >55 ms is a feasible and safe approach to stratify patients with regard to developing HAVB during a follow-up of 12 months.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
Cardiac Catheterization III: Left Heart Catheterization
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
